COVID-19: Recovery Rate Now Up To 41.61 %, Fatality Rate Down To 2.87 %
India has reported about 0.3 deaths per lakh population, which is amongst the lowest in the world.
by League Health DeskNEW DELHI: The Ministry of Health and Family Welfare (MoHFW) has informed that the recovery rate of patients from COVID-19 infection has now gone up to 41.61 per cent which was 7.1 per cent in March this year. Briefing media in New Delhi, a ministry official said that the fatality rate due to coronavirus infection has come down to 2.87 per cent from 3.30 per cent, which is amongst the lowest in the world.
He said, due to the lockdown and containment measures taken by the government, 10.7 cases per lakh population have been reported in India as compared to 69.9 COVID-19 cases per lakh population for the world as a whole.
The official said 4.5 deaths per lakh population have been reported for the world, while India has reported about 0.3 deaths per lakh population, which is amongst the lowest in the world.
The Health Ministry official also appealed to people to maintain hand hygiene and social distancing and wear masks while stepping out.
“There is a need to focus on prevention and containment measures to contain the spread of COVID19 infection. About fifty per cent of deaths reported among elderly people while 73 per cent reported in the patients with comorbidity,” he said.
ICMR Director-General said that currently over one lakh samples for COVID-19 are being tested in a day.
The country has now 612 labs out of which 430 are government labs and 182 are private labs.
On the use of Hydroxychloroquine (HCQ) drug, the ICMR DG said that HCQ has been widely used against malaria and considering its anti-viral properties, in-vitro study data and availability and safety, ICMR had recommended it as a preventive treatment on a trial basis under supervision.
In fact, it has expanded the use of HCQ to frontline workers also, considering the potential benefits.
He said that no major side-effects of HCQ have been found in studies in India except nausea and vomiting and its use should be continued in preventive treatment for COVID-19.
He said it has been clearly advised that HCQ should be taken with food, not on empty stomach.
The ICMR also emphasized that one ECG should be done during the treatment.